The Lancet Oncology: September 28, 2009

The Lancet Oncology in conversation with - A podcast by The Lancet Group

Categories:

Education

Rob Brierley discusses an antithrombolic agent for patients receiving chemotherapy for solid tumours. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv